Terms: = Head and neck cancer AND MAP2K1, MAPKK1, 5604, ENSG00000169032, Q02750, MEK1, MKK1, PRKMK1 AND Diagnosis
4 results:
1. AKT-independent signaling in PIK3CA-mutant thyroid cancer mediates resistance to dual SRC and mek1/2 inhibition.
Rose MM; Nassar KW; Sharma V; Schweppe RE
Med Oncol; 2023 Sep; 40(10):299. PubMed ID: 37713162
[TBL] [Abstract] [Full Text] [Related]
2. MiR-942-5p inhibits tumor migration and invasion through targeting CST1 in esophageal squamous cell carcinoma.
Zhang L; Yu S; Yin X; Tu M; Cai L; Zhang Y; Yu L; Zhang S; Pan X; Huang Y
PLoS One; 2023; 18(2):e0277006. PubMed ID: 36848349
[TBL] [Abstract] [Full Text] [Related]
3. Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinoma.
Ye F; Gao H; Xiao L; Zuo Z; Liu Y; Zhao Q; Chen H; Feng W; Fu B; Sun L; Jiang X; He D; Jiang H; Yang M; Li L; Chen F; Liu X; Li S; Li Z; Jiang Y; Cheng L; Bu H
Int J Cancer; 2019 Mar; 144(6):1321-1330. PubMed ID: 30132833
[TBL] [Abstract] [Full Text] [Related]
4. Rab25 is a tumor suppressor gene with antiangiogenic and anti-invasive activities in esophageal squamous cell carcinoma.
Tong M; Chan KW; Bao JY; Wong KY; Chen JN; Kwan PS; Tang KH; Fu L; Qin YR; Lok S; Guan XY; Ma S
Cancer Res; 2012 Nov; 72(22):6024-35. PubMed ID: 22991305
[TBL] [Abstract] [Full Text] [Related]
